UNSPSC 51192314: Potassium chloride/sodium chloride/tromethamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class TN900. This VA Drug Class (TN900) classifies this compound as belonging to the group THERAPEUTIC NUTRIENTS/MINERALS/ELECTROLYES, OTHER.

UNSPSC 51192314 Potassium chloride/sodium chloride/tromethamine is a Commodity code that encompasses chemical supply for water treatment and municipal infrastructure operations, alongside generic pharmaceuticals and over-the-counter products distributed through state and local government health and facility networks. State and local governments procure these commodities primarily for water pollution control facilities, public health systems, and multistate cooperative purchasing networks that serve participating state agencies and local government entities across multiple states. The issuing bodies include municipalities (city water and wastewater departments), state departments of administration overseeing multistate cooperative purchasing alliances, and participating members of cooperative purchasing vehicles such as MMCAP. The scope reflects dual use cases: chemical treatment supplies for water infrastructure and generic pharmaceutical products for state and local health systems.

Recent activity spans Connecticut and Minnesota. The City of Meriden issued an IFB (solicitation B02715) on July 8, 2026, for sodium bisulfite chemical supply to its Water Pollution Control Facility, with bids due July 29, 2026. The Minnesota Department of Administration, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued an RFP (S1070000015802) on January 20, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products for distribution across participating state and local government facilities including Oregon, with proposals due March 26, 2026. MMCAP's procurement requires vendors to supply through authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson), maintain compliance with cGMP and the Drug Supply Chain Security Act, and accept a 3 percent administrative fee on all contract purchases. The competitive evaluation for MMCAP weights price competitiveness at 75 percent, with secondary factors including fixed pricing, administrative compliance, and EDI capability weighted at 5 to 10 percent each.